Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
0.9910
+0.0431 (4.55%)
At close: May 12, 2025, 4:00 PM
1.010
+0.019 (1.91%)
After-hours: May 12, 2025, 6:18 PM EDT
Shattuck Labs Revenue
Shattuck Labs had revenue of $4.61M in the twelve months ending March 31, 2025, up 69.65% year-over-year. In the year 2024, Shattuck Labs had annual revenue of $5.72M with 245.26% growth.
Revenue (ttm)
$4.61M
Revenue Growth
+69.65%
P/S Ratio
10.94
Revenue / Employee
$104,682
Employees
44
Market Cap
47.47M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
STTK News
- 11 days ago - Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - GlobeNewsWire
- 3 months ago - Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - GlobeNewsWire
- 3 months ago - Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis Congress - GlobeNewsWire
- 4 months ago - Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025 - GlobeNewsWire